162 related articles for article (PubMed ID: 37693262)
21. The role of antibody induction in liver transplantation.
Eason JD
Curr Opin Organ Transplant; 2007 Jun; 12(3):242-244. PubMed ID: 27711011
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.
Toso C; Merani S; Bigam DL; Shapiro AM; Kneteman NM
Hepatology; 2010 Apr; 51(4):1237-43. PubMed ID: 20187107
[TBL] [Abstract][Full Text] [Related]
23. Syngeneic living-donor liver transplantation without the use of immunosuppression.
Liu LU; Schiano TD; Min AD; Kim-Schluger L; Schwartz ME; Emre S; Fishbein TM; Bodenheimer HC; Miller CM
Gastroenterology; 2002 Oct; 123(4):1341-5. PubMed ID: 12360494
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD007606. PubMed ID: 29630730
[TBL] [Abstract][Full Text] [Related]
25. Liver transplantation at the University of Texas Health Science Center/University Hospital in San Antonio.
Halff G; Speeg KV; Washburn K; Esterl R; Abrahamian G; Mejia A; Nichols L; Neigut D; Dodd G; Cigarroa F
Clin Transpl; 2003; ():247-53. PubMed ID: 15387116
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
Cochrane Database Syst Rev; 2015 Dec; (12):CD007606. PubMed ID: 26666504
[TBL] [Abstract][Full Text] [Related]
27. Tolerance after liver transplantation: Where are we?
Feng S; Bucuvalas J
Liver Transpl; 2017 Dec; 23(12):1601-1614. PubMed ID: 28834221
[TBL] [Abstract][Full Text] [Related]
28. Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.
Ferreiro AO; Vazquez-Millán MA; López FS; Gutiérrez MG; Diaz SP; Patiño MJ
Transplant Proc; 2014 Dec; 46(10):3496-501. PubMed ID: 25498079
[TBL] [Abstract][Full Text] [Related]
29. Centrilobular necrosis in children after combined liver and small bowel transplantation.
Lacaille F; Canioni D; Fournet JC; Revillon Y; Cezard JP; Goulet O
Transplantation; 2002 Jan; 73(2):252-7. PubMed ID: 11821740
[TBL] [Abstract][Full Text] [Related]
30. Minimalization of immunosuppression in liver transplantation: steps from 'how' to 'now'. Interview by Emily Reeve.
Lerut J
Expert Rev Clin Immunol; 2012 Sep; 8(7):605-7. PubMed ID: 23078057
[TBL] [Abstract][Full Text] [Related]
31. Effects of re-augmenting maintenance immunosuppression on post-transplant donor-specific HLA antibodies in liver transplantation.
Tokodai K; Miyagi S; Nakanishi W; Fujio A; Kashiwadate T; Goto M; Unno M; Kamei T
Transpl Immunol; 2020 Dec; 63():101334. PubMed ID: 32919028
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
[TBL] [Abstract][Full Text] [Related]
33. Auxiliary liver transplantation for management of acute liver failure in children - Systematic review.
Quadros J; Piedade C; Lopes MF
Transplant Rev (Orlando); 2021 Dec; 35(4):100631. PubMed ID: 34098491
[TBL] [Abstract][Full Text] [Related]
34. Liver transplantation for HIV/hepatitis C virus co-infected patients.
Takatsuki M; Soyama A; Eguchi S
Hepatol Res; 2014 Jan; 44(1):17-21. PubMed ID: 23607831
[TBL] [Abstract][Full Text] [Related]
35. Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation.
Bonaccorsi-Riani E; Pennycuick A; Londoño MC; Lozano JJ; Benítez C; Sawitzki B; Martínez-Picola M; Bohne F; Martínez-Llordella M; Miquel R; Rimola A; Sánchez-Fueyo A
Am J Transplant; 2016 Feb; 16(2):484-96. PubMed ID: 26517400
[TBL] [Abstract][Full Text] [Related]
36. Minimization of immunosuppression in adult liver transplantation: new strategies and tools.
Londoño MC; López MC; Sánchez-Fueyo A
Curr Opin Organ Transplant; 2010 Dec; 15(6):685-90. PubMed ID: 20885324
[TBL] [Abstract][Full Text] [Related]
37. Review on immunosuppression in liver transplantation.
Moini M; Schilsky ML; Tichy EM
World J Hepatol; 2015 Jun; 7(10):1355-68. PubMed ID: 26052381
[TBL] [Abstract][Full Text] [Related]
38. Effect of delayed CNI-based immunosuppression with Advagraf® on liver function after MELD-based liver transplantation [IMUTECT].
Richter S; Polychronidis G; Gotthardt DN; Houben P; Giese T; Sander A; Dörr-Harim C; Diener MK; Schemmer P
BMC Surg; 2014 Sep; 14():64. PubMed ID: 25178675
[TBL] [Abstract][Full Text] [Related]
39. Temporary Cessation of Immunosuppression for Infection May Contribute to the Development of Graft-vs-Host Disease After ABO-Incompatible Living Donor Liver Transplantation: A Case Report.
Kim KJ; Lee TB; Yang KH; Ryu JH; Choi BH; Lee HJ; Lee SM; Kim IS
Transplant Proc; 2019 Nov; 51(9):3136-3139. PubMed ID: 31611115
[TBL] [Abstract][Full Text] [Related]
40. Management of Immunosuppression in Liver Transplantation.
Dhanasekaran R
Clin Liver Dis; 2017 May; 21(2):337-353. PubMed ID: 28364817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
